O​pen funding and investment opportunities​

Please find below a list of opportunities available to you

 

Circular economy and Green chemistry and Industrial ash valorization | Ref: 0726

  • Funding required:  2.2M € private funding. 0.96M € OPEX
  • Sector of activity:  with a capacity over 12.000 tones/year, this plant  transforms industrial ash into CaCO3 and fertilizers.
  • Other details:  ROI positive within 2 years. 1.39M € expected revenue by 2028 and 2.32M € by 2029.


Govtech and Medtech and data models | Ref: 0626

  • Funding required:  150k € private funding, 10% anual interest, returned to investors within 6 months.
  • Sector of activity:  this company is maturing an artificial intelligence platform for optimal managing of human migration and mobility.
  • Other details:  the platform is already functional and seeking to broaden services in an increasing number of countries within Europe and EMEA regions.

Edtech and Medtech | Ref: 0526

  • Funding required: Currently seeking a combination of non-dilutive financing and convertible notes.
  • Sector of activity: Med-tech and Ed-tech.
  • Other details: Following the close of a 1M € pre-seed round, the Founders retain over 80% equity. Team: We have 10+ full-time staff and highly engaged top-tier advisors, some of whom have already invested. Location: Headquartered in Spain. Locations in Navarra, Barcelona and Madrid. Business Model: Highly scalable, accessible product with a large TAM (Total Addressable Market). Applicable globally to healthcare students/professionals (B2C) and clinics, hospitals & universities (B2B).

Novel device for Alzheimer, Parkinson and neurodegeneration | Ref: 0426

  • Funding required: 100k-300k eur Investment Opportunity: Medical Device for Neurodegenerative Diseases.
  • Sector of activity: Funding sought to develop a medical device enhancing efficacy & safety of therapies for Alzheimer’s, Parkinson’s & related conditions.
  • Other details: Now entering human clinical trials. Early-stage investors can participate via a convertible loan note.

Novel therapies with IA | Ref: 0326

  • Funding required: 3.5M € in 2026. Bridge round of up to 400k € in discounted convertible notes available until end of August 2025. Funds will cover preclinical development and manufacturing expenses required to advance the lead candidate to clinical trials in humans.
  • Sector of activity: Medtech. Novel therapeutic products designed with support of cutting-edge IA tools. Innovative therapeutic approach with AI-designed compounds. Efficacy data in animal models already available. Return: anticipated 20x+ multiplier at exit for investors in this 2025 round. Exit planned for 2030.
  • Other details: solid scientific foundation team, clear development roadmap and long-term vision. Global market, projected to surpass $44B by 2032.

Chemical engineering and green hydrogen | Ref: 0226

  • Funding required: 750k €. Funds will cover cash flow for the development, there is a minimum viable product previously developed in collaboration with a Technology Center.
  • Sector of activity: Medtech and Edtech. Investment Opportunity in Chemical Engineering Project: Efficient Hydrolysis and Green Hydrogen Generation.
  • Other details: 10% return per annum on invested capital (from investment date), structured as debt with an option to convert into equity upon proven profitability. Guarantee: Established company with a solid track record and diversified operations. Holds a granted subsidy amounting to 2.8M €.

Health and Artificial Intelligence | Ref: 0126

  • Funding required: 150k €
  • Sector of activity: Medtech and Edtech. Investment Opportunity in Health-tech & artificial intelligence. Innovative company with strong project portfolio and growth potential.
  • Other details: 10% return per annum on invested capital (from investment date). Guarantee: Company holds a pending VAT refund (reimbursement expected before end of July).

 

Frequently Asked Questions about Funding and Investment

What are the best options for funding scientific research or Deep Tech projects?

Raising capital for scientific projects (Deep Tech) is different from funding a traditional company, as it requires longer development times and a high level of technical knowledge. At KnowTransfer, we recommend diversifying funding sources across the following stages:

  • Public Grants (Non-dilutive capital): Ideal for the early stages (proof of concept). It allows the research to advance without giving up a percentage of the company.
  • Specialised Business Angels (Smart Money): Private investors who provide not only capital but also technical industry knowledge and key contacts for the Go-to-Market phase.
  • Deep Tech Venture Capital: Venture capital funds specialised in technology transfer. They come into play when the technology is validated and ready to scale commercially.
  • Technology Marketplaces: Platforms that directly connect your innovation with corporate industrial companies looking to acquire new technologies.

Ready to value your tech? Contact us.

Contact us